Hemant Misra
Corporate Officer/Principal bij Prolong Pharmaceuticals LLC
Profiel
Hemant Misra is currently the Vice President of Clinical Development at Prolong Pharmaceuticals LLC since 2011.
Prior to this, he worked as the Director of Clinical Drug and Corporate Development at rEVO Biologics, Inc. and as the Head of Development and Quality System at ActiveCyte, Inc.
Actieve functies van Hemant Misra
| Bedrijven | Functie | Begin |
|---|---|---|
Prolong Pharmaceuticals LLC
 Prolong Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Prolong Pharmaceuticals LLC develops and manufactures biopharmaceutical products to treat anemias, cancers and their debilitating comorbidities. The firm focuses on sickle cell anemia, diabetic ischemia, and several trauma indications. Its products include SANGUINATE, an oxygen transfer agent to treat anemia and protein therapeutics. The company was founded by Abraham Abuchowski in 2002 and is headquartered in South Plainfield, NJ. | Corporate Officer/Principal | 27-01-2011 |
Eerdere bekende functies van Hemant Misra
| Bedrijven | Functie | Einde |
|---|---|---|
| ActiveCyte, Inc. | Corporate Officer/Principal | - |
| REVO BIOLOGICS INC | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Prolong Pharmaceuticals LLC
Prolong Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Prolong Pharmaceuticals LLC develops and manufactures biopharmaceutical products to treat anemias, cancers and their debilitating comorbidities. The firm focuses on sickle cell anemia, diabetic ischemia, and several trauma indications. Its products include SANGUINATE, an oxygen transfer agent to treat anemia and protein therapeutics. The company was founded by Abraham Abuchowski in 2002 and is headquartered in South Plainfield, NJ. | Health Technology |
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |
| ActiveCyte, Inc. |